Futura Medical PLC
FUM
Company Profile
Business description
Futura Medical PLC is engaged in the development and commercialization of sexual health products. Its product Eroxon is a treatment for erectile dysfunction. Geographically, the company derives the majority of its revenue from the United Kingdom and the European Union.
Contact
40 Occam Road
Surrey Technology Centre
GuildfordSurreyGU2 7YG
GBRT: +44 1483685670
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
17
Stocks News & Analysis
stocks
Chart of the Week: Opportunities with wide-moat retailers
Consumer defensive names look undervalued.
stocks
New ASX share added to our best ideas
Earnings outlook is strong and the shares trade at a discount to our fair value.
stocks
Fair value downgraded for ASX heavyweight
Our capital allocation rating was also lowered due to balance sheet weakness.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,240.30 | 42.60 | 0.46% |
| CAC 40 | 8,060.17 | 93.22 | 1.17% |
| DAX 40 | 24,416.71 | 303.09 | 1.26% |
| Dow JONES (US) | 46,441.10 | 43.21 | 0.09% |
| FTSE 100 | 9,457.50 | 11.07 | 0.12% |
| HKSE | 27,287.12 | 431.56 | 1.61% |
| NASDAQ | 22,755.16 | 95.15 | 0.42% |
| Nikkei 225 | 44,936.73 | 385.88 | 0.87% |
| NZX 50 Index | 13,451.76 | 17.77 | 0.13% |
| S&P 500 | 6,711.20 | 22.74 | 0.34% |
| S&P/ASX 200 | 8,945.90 | 40.10 | 0.45% |
| SSE Composite Index | 3,882.78 | 20.25 | 0.52% |